Immunosuppressive drugs in rheumatoid arthritis.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000630:Aminopterin / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001327:Autoimmune Diseases; D001379:Azathioprine / Q000627:therapeutic use; D002699:Chlorambucil / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D009588:Nitrogen Mustard Compounds; D002699:Chlorambucil; D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone; D015122:Mercaptopurine; D010396:Penicillamine; D000630:Aminopterin; D001379:Azathioprine; D008727:Methotrexate